As of April 2024 Orchard Therapeutics has a market cap of $0.38 Billion. This makes Orchard Therapeutics the world's 6265th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2024 | $0.38 B | 1.67% |
2023 | $0.37 B | 695.42% |
2022 | $47 M | -71.63% |
2021 | $0.16 B | -60.98% |
2020 | $0.42 B | -68.14% |
2019 | $1.33 B | -1.33% |
2018 | $1.35 B |
Name | Market cap | Market cap differencediff. | Country |
---|---|---|---|
Organovo ONVO | $10.07 M | -97.35% | ๐บ๐ธ USA |
Orchard Therapeutics
ORTX | $0.38 B | 0.00% | ๐ฌ๐ง UK |
Novavax NVAX | $0.57 B | 50.59% | ๐บ๐ธ USA |
Novocure
NVCR | $1.35 B | 257.69% | Jersey |